In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.
In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.
In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.
10 min
About Targeted Talks
From the publisher's feed
Targeted Talks is a podcast series from Targeted Oncology featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology professionals.
For more visit: https://www.targetedonc.com/podcasts